CME
Price
$281.29
Change
-$0.76 (-0.27%)
Updated
Sep 4 closing price
Capitalization
101.15B
51 days until earnings call
Intraday BUY SELL Signals
NDAQ
Price
$96.88
Change
-$1.83 (-1.85%)
Updated
Sep 4 closing price
Capitalization
54.15B
44 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CME vs NDAQ

CME vs NDAQ Comparison Chart in %
View a ticker or compare two or three
VS
CME vs. NDAQ commentary
Sep 07, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CME is a StrongBuy and NDAQ is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2026
Stock price -- (CME: $281.29 vs. NDAQ: $96.88)
Brand notoriety: CME: Notable vs. NDAQ: Not notable
Both companies represent the Financial Publishing/Services industry
Current volume relative to the 65-day Moving Average: CME: 55% vs. NDAQ: 61%
Market capitalization -- CME: $101.15B vs. NDAQ: $54.15B
CME [@Financial Publishing/Services] is valued at $101.15B. NDAQ’s [@Financial Publishing/Services] market capitalization is $54.15B. The market cap for tickers in the [@Financial Publishing/Services] industry ranges from $130.75B to $0. The average market capitalization across the [@Financial Publishing/Services] industry is $44.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CME’s FA Score shows that 0 FA rating(s) are green whileNDAQ’s FA Score has 1 green FA rating(s).

  • CME’s FA Score: 0 green, 5 red.
  • NDAQ’s FA Score: 1 green, 4 red.
According to our system of comparison, CME is a better buy in the long-term than NDAQ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CME’s TA Score shows that 3 TA indicator(s) are bullish while NDAQ’s TA Score has 3 bullish TA indicator(s).

  • CME’s TA Score: 3 bullish, 5 bearish.
  • NDAQ’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CME is a better buy in the short-term than NDAQ.

Price Growth

CME (@Financial Publishing/Services) experienced а -1.58% price change this week, while NDAQ (@Financial Publishing/Services) price change was -2.45% for the same time period.

The average weekly price growth across all stocks in the @Financial Publishing/Services industry was -2.48%. For the same industry, the average monthly price growth was +5.16%, and the average quarterly price growth was +5.59%.

Reported Earning Dates

CME is expected to report earnings on Oct 28, 2026.

NDAQ is expected to report earnings on Oct 21, 2026.

Industries' Descriptions

@Financial Publishing/Services (-2.48% weekly)

The financial publishing /services sector includes companies that provide informational products and services that are of value to investors, financial/analytics professionals and other interested readers. The products include real-time stock quotes, financial news and analyses. Think S&P Global, Inc., Moody`s Corporation, Thomson-Reuters Corp and IHS Markit Ltd. Information is critical in making financial or investment decisions, and what makes this industry’s output relevant at all times, across various economic conditions.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CME($101B) has a higher market cap than NDAQ($54.2B). NDAQ has higher P/E ratio than CME: NDAQ (28.24) vs CME (23.86). CME YTD gains are higher at: 3.964 vs. NDAQ (0.417). CME has higher annual earnings (EBITDA): 6.1B vs. NDAQ (3.43B). NDAQ has more cash in the bank: 2.79B vs. CME (2.28B). CME has less debt than NDAQ: CME (3.42B) vs NDAQ (9.24B). NDAQ has higher revenues than CME: NDAQ (8.74B) vs CME (6.77B).
CMENDAQCME / NDAQ
Capitalization101B54.2B186%
EBITDA6.1B3.43B178%
Gain YTD3.9640.417950%
P/E Ratio23.8628.2484%
Revenue6.77B8.74B78%
Total Cash2.28B2.79B82%
Total Debt3.42B9.24B37%
FUNDAMENTALS RATINGS
CME vs NDAQ: Fundamental Ratings
CME
NDAQ
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
63
Fair valued
PROFIT vs RISK RATING
1..100
4729
SMR RATING
1..100
5452
PRICE GROWTH RATING
1..100
5034
P/E GROWTH RATING
1..100
5372
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CME's Valuation (61) in the Investment Banks Or Brokers industry is in the same range as NDAQ (63). This means that CME’s stock grew similarly to NDAQ’s over the last 12 months.

NDAQ's Profit vs Risk Rating (29) in the Investment Banks Or Brokers industry is in the same range as CME (47). This means that NDAQ’s stock grew similarly to CME’s over the last 12 months.

NDAQ's SMR Rating (52) in the Investment Banks Or Brokers industry is in the same range as CME (54). This means that NDAQ’s stock grew similarly to CME’s over the last 12 months.

NDAQ's Price Growth Rating (34) in the Investment Banks Or Brokers industry is in the same range as CME (50). This means that NDAQ’s stock grew similarly to CME’s over the last 12 months.

CME's P/E Growth Rating (53) in the Investment Banks Or Brokers industry is in the same range as NDAQ (72). This means that CME’s stock grew similarly to NDAQ’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CMENDAQ
RSI
ODDS (%)
Bearish Trend 4 days ago
36%
Bearish Trend 4 days ago
52%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
43%
Bearish Trend 4 days ago
57%
Momentum
ODDS (%)
Bullish Trend 4 days ago
55%
Bearish Trend 4 days ago
51%
MACD
ODDS (%)
Bearish Trend 4 days ago
38%
Bearish Trend 4 days ago
52%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
38%
Bearish Trend 4 days ago
49%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
54%
Bullish Trend 4 days ago
62%
Advances
ODDS (%)
Bullish Trend 15 days ago
50%
Bullish Trend 15 days ago
63%
Declines
ODDS (%)
Bearish Trend 28 days ago
42%
Bearish Trend 6 days ago
49%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
46%
Bearish Trend 4 days ago
51%
Aroon
ODDS (%)
Bullish Trend 4 days ago
54%
Bullish Trend 4 days ago
55%
View a ticker or compare two or three
Interact to see
Advertisement
CME
Daily Signal:
Gain/Loss:
NDAQ
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARMP5.840.32
+5.80%
Armata Pharmaceuticals
LEDS1.960.08
+4.26%
SemiLEDS Corp
RGTI15.200.02
+0.13%
Rigetti Computing
MET97.62-1.61
-1.62%
MetLife
IRMD83.45-3.14
-3.63%
iRadimed Corp

NDAQ and

Correlation & Price change

A.I.dvisor indicates that over the last year, NDAQ has been closely correlated with JEF. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if NDAQ jumps, then JEF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NDAQ
1D Price
Change %
NDAQ100%
-1.85%
JEF - NDAQ
71%
Closely correlated
+1.79%
MS - NDAQ
71%
Closely correlated
+0.26%
GS - NDAQ
70%
Closely correlated
+0.07%
RJF - NDAQ
69%
Closely correlated
-1.55%
SPGI - NDAQ
68%
Closely correlated
-1.57%
More